The cost of chronic wounds in Australia is estimated to be $3 Billion per year, impacting 420,000 Australians. Not only is this a national economic concern, but more importantly, is the suffering the person may be going through.
Australian Health Journal met with Hayley Ryan, Board Director and Chair at Wounds Australia and Director at WoundRescue to hear her work in chronic wound management, palliative wounds and pressure injury prevention to comfort those living with a wound.
Hayley has over 22 years’ experience in nursing and has 18 of these in wound care during this time. Hayley has a passion for healing wounds as a Clinical Nurse Consultant across Australia and New Zealand.
She gave testimony at the Royal Commission into Aged Care in July 2019, through the Wounds Australia’s submission, on several topics including: wound care statistics, the causes of wounds, prevention of wounds, the use of appropriate wound dressings, substandard wound care, and recommendations to improve wound management within aged care.
In this interview Hayley talks about how she first got interested in wound management before talking through the current issues with wound management in the Australian health system. These issues include access, education and awareness as a health priority.
Hayley also talks about Wounds Australia’s 11 Point Plan. It has been produced to be a clear and effective blueprint for governments to follow. The plan draws on the knowledge and skills of Australia’s top wound care experts to dramatically cut patient numbers and the funds to treat them.
There is a goal in handling the complications of delivering treatment across primary care, community care, hospital and aged care settings turning into a more defined and streamlined process.
In terms of growth in specialist wound care knowledge in health workers, Hayley talks about the education and training pathways health care professionals can take, including through Wounds Australia, Monash University and Wound Rescue.
-
Belonging in a medical device company
Edith de Boer is the HR Director for Zimmer Biomet in Australia and New Zealand. Her career originally was in telecommunications and consulting in Europe. After leaving The Netherlands, Edith worked into the Australian medical research industry, before moving into a human resources role at Zimmer Biomet. Edith spoke to Australian Health Journal about her role and the organisation.
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
-
Sovereign capability uplifted
Skilled labour, in particular skilled in the manufacture of MTP products, namely competency in Good Manufacturing Practice (GMP), was identified as one of the key priorities, according to Jarrod Belcher, Director of the REDI Program at MTPConnect. Through a competitive process, MTPConnect selected additional industry training providers to deliver new programs addressing key skills gaps in the sector workforce.
Launched in September 2022, one of these programs is GMP Uplift developed by the Centre for Biopharmaceutical Excellence (CBE). CBE bring experience across large and small Biologics, Pharmaceuticals and Regenerative Medicine companies, both in consulting and GMP related enterprise training. CBE staff also have extensive experience in GMP operations, compliance, auditing and QMS design, a wide industry network for guest lecturers and readily available case studies.
